{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:01:31Z","timestamp":1784512891385,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["462540"],"award-info":[{"award-number":["462540"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["310651"],"award-info":[{"award-number":["310651"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder that accelerates atherosclerosis and leads to premature cardiovascular diseases (CVD). Whole food, plant-based diets (WFPB) are recommended worldwide for their cardioprotective properties but evidence regarding their effects in HeFH management remains unavailable. This study aims to evaluate the impact of a WFPB, in place of a standard American diet (SAD), on LDL-cholesterol (LDL-C) (primary outcome) and other CVD risk factors among adults with HeFH. In this randomized, two-period, two-treatment, crossover, controlled feeding trial, 50 adults with genetically confirmed HeFH, free of cholesterol-lowering medication, consumed a WFPB and a SAD for 4 weeks each in a random order, under fully controlled, isocaloric feeding conditions. The diets were separated by a two- to four-week washout period. LDL-C and other CVD risk factors were measured at the end of each diet. The WFPB induced a clinically significant reduction in LDL-C relative to the SAD (\u2009\u2212\u200917.9%, 95% CI: \u221221.7%, \u221214.3%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.0001). The study demonstrates the clinical significance of diet therapy in HeFH and supports its re-establishment as a cornerstone in clinical guidelines (clinicaltrials.gov registration: NCT05181553; funding: Canadian Institutes of Health Research).\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-73468-4","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:16:30Z","timestamp":1779257790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of a whole food, plant-based diet on LDL-cholesterol and cardiovascular risk factors in adults with heterozygous familial hypercholesterolemia: a randomized, two-period, two-treatment, crossover, fully controlled feeding trial"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6160-0267","authenticated-orcid":false,"given":"Jacob","family":"Lessard-Lord","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Guay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2210-2433","authenticated-orcid":false,"given":"Maryka","family":"Rancourt-Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6848-6559","authenticated-orcid":false,"given":"Anne","family":"Gangloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Greffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-5387","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Rudkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6733-4801","authenticated-orcid":false,"given":"Jean-Philippe","family":"Drouin-Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"73468_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","volume":"16","author":"AJ Berberich","year":"2019","unstructured":"Berberich, A. J. & Hegele, R. A. The complex molecular genetics of familial hypercholesterolaemia. Nat. Rev. Cardiol. 16, 9\u201320 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"73468_CR2","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","volume":"75","author":"SO Beheshti","year":"2020","unstructured":"Beheshti, S. O., Madsen, C. M., Varbo, A. & Nordestgaard, B. G. Worldwide prevalence of familial hypercholesterolemia. JACC 75, 2553\u20132566 (2020).","journal-title":"JACC"},{"key":"73468_CR3","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","volume":"141","author":"P Hu","year":"2020","unstructured":"Hu, P. et al. Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease. Circulation 141, 1742\u20131759 (2020).","journal-title":"Circulation"},{"key":"73468_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cjco.2020.09.010","volume":"3","author":"J-P Drouin-Chartier","year":"2021","unstructured":"Drouin-Chartier, J.-P. et al. Correlates of coronary artery calcification prevalence and severity in patients with heterozygous familial hypercholesterolemia. CJC Open 3, 62\u201370 (2021).","journal-title":"CJC Open"},{"key":"73468_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/humu.1380010602","volume":"1","author":"HH Hobbs","year":"1992","unstructured":"Hobbs, H. H., Brown, M. S. & Goldstein, J. L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1, 445\u2013466 (1992).","journal-title":"Hum. Mutat."},{"key":"73468_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0021-9150(98)00268-8","volume":"143","author":"D Gaudet","year":"1999","unstructured":"Gaudet, D. et al. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25\u201349 years) versus middle-aged (50\u201364 years) men. Atherosclerosis 143, 153\u2013161 (1999).","journal-title":"Atherosclerosis"},{"key":"73468_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","volume":"5","author":"ROTGFH Community","year":"2020","unstructured":"Community, R. O. T. G. F. H. Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action. JAMA Cardiol. 5, 217\u2013229 (2020).","journal-title":"JAMA Cardiol."},{"key":"73468_CR8","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1016\/S2542-5196(20)30162-5","volume":"4","author":"V Miller","year":"2020","unstructured":"Miller, V., Webb, P., Micha, R. & Mozaffarian, D. Defining diet quality: a synthesis of dietary quality metrics and their validity for the double burden of malnutrition.  Lancet Planet. Health 4, e352\u2013e370 (2020).","journal-title":"Lancet Planet. Health"},{"key":"73468_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1001\/jamainternmed.2020.2176","volume":"180","author":"Z Shan","year":"2020","unstructured":"Shan, Z. et al. Association between healthy eating patterns and risk of cardiovascular disease. JAMA Intern. Med. 180, 1090\u20131100 (2020).","journal-title":"JAMA Intern. Med."},{"key":"73468_CR10","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/10408398.2017.1392288","volume":"59","author":"A Bechthold","year":"2019","unstructured":"Bechthold, A. et al. Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies. Crit. Rev. Food Sci. Nutr. 59, 1071\u20131090 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"73468_CR11","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.jand.2020.08.076","volume":"120","author":"J Morze","year":"2020","unstructured":"Morze, J., Danielewicz, A., Hoffmann, G. & Schwingshackl, L. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: a second update of a systematic review and meta-analysis of cohort studies. J. Acad. Nutr. Diet. 120, 1998\u20132031.e1915 (2020).","journal-title":"J. Acad. Nutr. Diet."},{"key":"73468_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/ajcn\/nqaa107","volume":"112","author":"Y Heianza","year":"2020","unstructured":"Heianza, Y. et al. Genetic susceptibility, plant-based dietary patterns, and risk of cardiovascular disease.  Am. J. Clin. Nutr. 112, 220\u2013228 (2020).","journal-title":"Am. J. Clin. Nutr."},{"key":"73468_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/nutrit\/nux030","volume":"75","author":"Y Yokoyama","year":"2017","unstructured":"Yokoyama, Y., Levin, S. M. & Barnard, N. D. Association between plant-based diets and plasma lipids: a systematic review and meta-analysis. Nutr. Rev. 75, 683\u2013698 (2017).","journal-title":"Nutr. Rev."},{"key":"73468_CR14","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7326\/0003-4819-142-9-200505030-00007","volume":"142","author":"CD Gardner","year":"2005","unstructured":"Gardner, C. D. et al. The effect of a plant-based diet on plasma lipids in hypercholesterolemic adults. Ann. Intern. Med. 142, 725\u2013733 (2005).","journal-title":"Ann. Intern. Med."},{"key":"73468_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.2011.1202","volume":"306","author":"DJA Jenkins","year":"2011","unstructured":"Jenkins, D. J. A. et al. Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial. JAMA 306, 831\u2013839 (2011).","journal-title":"JAMA"},{"key":"73468_CR16","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1161\/CIRCULATIONAHA.118.035225","volume":"139","author":"M Guasch-Ferr\u00e9","year":"2019","unstructured":"Guasch-Ferr\u00e9, M. et al. Meta-analysis of randomized controlled trials of red meat consumption in comparison with various comparison diets on cardiovascular risk factors. Circulation 139, 1828\u20131845 (2019).","journal-title":"Circulation"},{"key":"73468_CR17","first-page":"1553","volume":"34","author":"LR Brunham","year":"2018","unstructured":"Brunham, L. R. et al. Canadian cardiovascular society position statement on familial hypercholesterolemia: update 2018. Can. J. Cardiol. 34, 1553\u20131563 (2018).","journal-title":"Can. J. Cardiol."},{"key":"73468_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/nu13010235","volume":"13","author":"G Roy","year":"2021","unstructured":"Roy, G., Boucher, A., Couture, P. & Drouin-Chartier, J.-P. Impact of diet on plasma lipids in individuals with heterozygous familial hypercholesterolemia: a systematic review of randomized controlled nutritional studies. Nutrients 13, 235 (2021).","journal-title":"Nutrients"},{"key":"73468_CR19","doi-asserted-by":"publisher","first-page":"e030290","DOI":"10.1136\/bmjopen-2019-030290","volume":"9","author":"FJ Kinnear","year":"2019","unstructured":"Kinnear, F. J. et al. Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis. BMJ Open 9, e030290 (2019).","journal-title":"BMJ Open"},{"key":"73468_CR20","doi-asserted-by":"publisher","unstructured":"Crossnohere, N. L. et al. Patient-reported outcome measures add value as clinical trial endpoints. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03906-1 (2025).","DOI":"10.1038\/s41591-025-03906-1"},{"key":"73468_CR21","first-page":"355","volume":"10","author":"TJ O\u2019Leary","year":"1987","unstructured":"O\u2019Leary, T. J. et al. Changes in serum lipoproteins and high-density lipoprotein composition during isotretinoin therapy. Clinical and investigative medicine. Med. Clin. Exp. 10, 355\u2013360 (1987).","journal-title":"Med. Clin. Exp."},{"key":"73468_CR22","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/0091270009336736","volume":"49","author":"G Charach","year":"2009","unstructured":"Charach, G., Kaysar, N., Grosskopf, I., Rabinovich, A. & Weintraub, M. Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.  J. Clin. Pharmacol. 49, 848\u2013851 (2009).","journal-title":"J. Clin. Pharmacol."},{"key":"73468_CR23","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1053\/meta.2002.35578","volume":"51","author":"DJA Jenkins","year":"2002","unstructured":"Jenkins, D. J. A. et al. A dietary portfolio approach to cholesterol reduction: Combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metab. Clin. Exp. 51, 1596\u20131604 (2002).","journal-title":"Metab. Clin. Exp."},{"key":"73468_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","volume":"61","author":"L Chiavaroli","year":"2018","unstructured":"Chiavaroli, L. et al. Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials. Prog. Cardiovas. Dis. 61, 43\u201353 (2018).","journal-title":"Prog. Cardiovas. Dis."},{"key":"73468_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","volume":"77","author":"RP Mensink","year":"2003","unstructured":"Mensink, R. P., Zock, P. L., Kester, A. D. M. & Katan, M. B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials12.  Am. J. Clin. Nutr. 77, 1146\u20131155 (2003).","journal-title":"Am. J. Clin. Nutr."},{"key":"73468_CR26","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","volume":"63","author":"RH Eckel","year":"2014","unstructured":"Eckel, R. H. et al. 2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2960\u20132984 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73468_CR27","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference, B. A. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 38, 2459\u20132472 (2017).","journal-title":"Eur. Heart J."},{"key":"73468_CR28","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader, D. J. & Hovingh, G. K. HDL and cardiovascular disease.  Lancet 384, 618\u2013625 (2014).","journal-title":"Lancet"},{"key":"73468_CR29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1800389","volume":"378","author":"R Estruch","year":"2018","unstructured":"Estruch, R. et al. Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. N. Engl. J. Med. 378, e34 (2018).","journal-title":"N. Engl. J. Med."},{"key":"73468_CR30","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1161\/ATVBAHA.121.316106","volume":"41","author":"M Paquette","year":"2021","unstructured":"Paquette, M. et al. Familial hypercholesterolemia-risk-score: a new score predicting cardiovascular events and cardiovascular mortality in familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 41, 2632\u20132640 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"73468_CR31","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1161\/CIRCULATIONAHA.123.065551","volume":"148","author":"AJ Glenn","year":"2023","unstructured":"Glenn, A. J. et al. Portfolio diet score and risk of cardiovascular disease: findings from 3 prospective cohort studies. Circulation 148, 1750\u20131763 (2023).","journal-title":"Circulation"},{"key":"73468_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0021-9150(94)90064-7","volume":"110","author":"PM Clifion","year":"1994","unstructured":"Clifion, P. M., Noakes, M. & Nestel, P. J. Gender and diet interactions with simvastatin treatment. Atherosclerosis 110, 25\u201333 (1994).","journal-title":"Atherosclerosis"},{"key":"73468_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0021-9150(92)90200-Z","volume":"93","author":"PM Clifton","year":"1992","unstructured":"Clifton, P. M., Wight, M. B. & Nestel, P. J. Is fat restriction needed with HMGCoA reductase inhibitor treatment?. Atherosclerosis 93, 59\u201370 (1992).","journal-title":"Atherosclerosis"},{"key":"73468_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jama.287.5.598","volume":"287","author":"A Jula","year":"2002","unstructured":"Jula, A. et al. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic MenA randomized controlled trial. JAMA 287, 598\u2013605 (2002).","journal-title":"JAMA"},{"key":"73468_CR35","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jama.1991.03460080067034","volume":"265","author":"MM Cobb","year":"1991","unstructured":"Cobb, M. M., Teitelbaum, H. S. & Breslow, J. L. Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets. JAMA 265, 997\u20131001 (1991).","journal-title":"JAMA"},{"key":"73468_CR36","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1056\/NEJM199304293281701","volume":"328","author":"DB Hunninghake","year":"1993","unstructured":"Hunninghake, D. B. et al. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. N. Engl. J. Med. 328, 1213\u20131219 (1993).","journal-title":"N. Engl. J. Med."},{"key":"73468_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.05.040","volume":"277","author":"LR Brunham","year":"2018","unstructured":"Brunham, L. R. et al. Familial hypercholesterolemia in Canada: initial results from the FH Canada national registry. Atherosclerosis 277, 419\u2013424 (2018).","journal-title":"Atherosclerosis"},{"key":"73468_CR38","first-page":"311","volume":"38","author":"G Roy","year":"2022","unstructured":"Roy, G. et al. Influence of the LDL-receptor genotype on statin response in heterozygous familial hypercholesterolemia: insights from the Canadian FH registry. Can. J. Cardiol. 38, 311\u2013319 (2022).","journal-title":"Can. J. Cardiol."},{"key":"73468_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0624-z","volume":"18","author":"P Surampudi","year":"2016","unstructured":"Surampudi, P., Enkhmaa, B., Anuurad, E. & Berglund, L. Lipid lowering with soluble dietary fiber. Curr. Atheroscler. Rep. 18, 75 (2016).","journal-title":"Curr. Atheroscler. Rep."},{"key":"73468_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jand.2016.09.021","volume":"117","author":"JW McRorie Jr.","year":"2017","unstructured":"McRorie, J. W. Jr. & McKeown, N. M. Understanding the physics of functional fibers in the gastrointestinal tract: an evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J. Acad. Nutr. Diet. 117, 251\u2013264 (2017).","journal-title":"J. Acad. Nutr. Diet."},{"key":"73468_CR41","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1194\/jlr.M500260-JLR200","volume":"46","author":"L Jakulj","year":"2005","unstructured":"Jakulj, L. et al. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels. J. Lipid Res. 46, 2692\u20132698 (2005).","journal-title":"J. Lipid Res."},{"key":"73468_CR42","doi-asserted-by":"publisher","unstructured":"Kuosmanen, S. et al. Barriers associated with pulse and plant-based meat alternative consumption across sociodemographic groups: a capability, opportunity, motivation, behaviour model approach. Front. Nutr. 10, 2023, https:\/\/doi.org\/10.3389\/fnut.2023.1186165 (2023).","DOI":"10.3389\/fnut.2023.1186165"},{"key":"73468_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40795-025-01100-7","volume":"11","author":"J Yang","year":"2025","unstructured":"Yang, J., Bernard, L., Ting, A., Sullivan, V. K. & Rebholz, C. M. Perceived motivators and barriers to consuming a plant-based diet: a qualitative research study. BMC Nutr. 11, 108 (2025).","journal-title":"BMC Nutr."},{"key":"73468_CR44","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3390\/nu16060823","volume":"16","author":"A Rickerby","year":"2024","unstructured":"Rickerby, A. & Green, R. Barriers to adopting a plant-based diet in high-income countries: a systematic review. Nutrients 16, 823 (2024).","journal-title":"Nutrients"},{"key":"73468_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.numecd.2011.05.005","volume":"21","author":"TA Miettinen","year":"2011","unstructured":"Miettinen, T. A., Gylling, H. & Nissinen, M. J. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr. Metab. Cardiovasc. Dis. 21, 765\u2013769 (2011).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"73468_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. & the, C. G. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 8, 18 (2010).","journal-title":"BMC Med."},{"key":"73468_CR47","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1136\/bmj.316.7146.1719","volume":"316","author":"B Sibbald","year":"1998","unstructured":"Sibbald, B. & Roberts, C. Understanding controlled trials; crossover trials. BMJ 316, 1719 (1998).","journal-title":"BMJ"},{"key":"73468_CR48","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","volume":"32","author":"H Lennern\u00e4s","year":"1997","unstructured":"Lennern\u00e4s, H. & Fager, G. Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors. Clin. Pharmacokinet. 32, 403\u2013425 (1997).","journal-title":"Clin. Pharmacokinet."},{"key":"73468_CR49","first-page":"13a","volume":"10","author":"C Simard","year":"2003","unstructured":"Simard, C. & Turgeon, J. The pharmacokinetics of ezetimibe. Can. J. Clin. Pharmacol. 10, 13a\u201320a (2003).","journal-title":"Can. J. Clin. Pharmacol."},{"key":"73468_CR50","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40262-017-0620-7","volume":"57","author":"S Kasichayanula","year":"2018","unstructured":"Kasichayanula, S. et al. Clinical pharmacokinetics and pharmacodynamics of evolocumab, a PCSK9 inhibitor. Clin. Pharmacokinet. 57, 769\u2013779 (2018).","journal-title":"Clin. Pharmacokinet."},{"key":"73468_CR51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ejcn.2011.163","volume":"66","author":"M\u00c8 Labont\u00e9","year":"2012","unstructured":"Labont\u00e9, M. \u00c8, Cyr, A., Baril-Gravel, L., Royer, M. M. & Lamarche, B. Validity and reproducibility of a web-based, self-administered food frequency questionnaire. Eur. J. Clin. Nutr. 66, 166\u2013173 (2012).","journal-title":"Eur. J. Clin. Nutr."},{"key":"73468_CR52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ajcn.81.2.380","volume":"81","author":"DJA Jenkins","year":"2005","unstructured":"Jenkins, D. J. A. et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants1\u201332.  Am. J. Clin. Nutr. 81, 380\u2013387 (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"73468_CR53","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1139\/apnm-2021-0415","volume":"47","author":"D Brassard","year":"2022","unstructured":"Brassard, D. et al. Development of the Healthy Eating Food Index (HEFI)\u22122019 measuring adherence to Canada\u2019s Food Guide 2019 recommendations on healthy food choices. Appl. Physiol. Nutr. Metab. 47, 595\u2013610 (2022).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"73468_CR54","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jand.2023.05.015","volume":"123","author":"MM Shams-White","year":"2023","unstructured":"Shams-White, M. M. et al. Healthy Eating Index-2020: review and update process to reflect the dietary guidelines for Americans, 2020-2025. J. Acad. Nutr. Dietet. 123, 1280\u20131288 (2023).","journal-title":"J. Acad. Nutr. Dietet."},{"key":"73468_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0021-9150(03)00243-0","volume":"170","author":"J Goulet","year":"2003","unstructured":"Goulet, J., Lamarche, B., Nadeau, G. & Lemieux, S. Effect of a nutritional intervention promoting the Mediterranean food pattern on plasma lipids, lipoproteins and body weight in healthy French-Canadian women. Atherosclerosis 170, 115\u2013124 (2003).","journal-title":"Atherosclerosis"},{"key":"73468_CR56","first-page":"1665","volume":"34","author":"D Brassard","year":"2018","unstructured":"Brassard, D. et al. Poor adherence to dietary guidelines among French-speaking adults in the province of Quebec, Canada: the PREDISE study. Can. J. Cardiol. 34, 1665\u20131673 (2018).","journal-title":"Can. J. Cardiol."},{"key":"73468_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-019-0474-y","volume":"18","author":"D Brassard","year":"2019","unstructured":"Brassard, D. et al. Consumption of low nutritive value foods and cardiometabolic risk factors among French-speaking adults from Quebec, Canada: the PREDISE study. Nutr. J. 18, 49 (2019).","journal-title":"Nutr. J."},{"key":"73468_CR58","doi-asserted-by":"publisher","unstructured":"Ngueta, G., Blanchette, C., Mondor, M., Moubarac, J. C. & Lucas, M. Canadians adults fail their dietary quality examination twice. Nutrients 15 https:\/\/doi.org\/10.3390\/nu15030637 (2023).","DOI":"10.3390\/nu15030637"},{"key":"73468_CR59","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S1368980017000234","volume":"21","author":"CA Monteiro","year":"2018","unstructured":"Monteiro, C. A. et al. The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr. 21, 5\u201317 (2018).","journal-title":"Public Health Nutr."},{"key":"73468_CR60","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/eurheartj\/ehz601","volume":"40","author":"CG Schrock","year":"2019","unstructured":"Schrock, C. G. Lipoprotein(a): it is not the cholesterol content: it is the apolipoprotein(a)!. Eur. Heart J. 40, 3576\u20133576 (2019).","journal-title":"Eur. Heart J."},{"key":"73468_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.016318","volume":"9","author":"P Willeit","year":"2020","unstructured":"Willeit, P. et al. Low-density lipoprotein cholesterol corrected for lipoprotein(a) cholesterol, risk thresholds, and cardiovascular events. J. Am. Heart Assoc. 9, e016318 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"73468_CR62","unstructured":"Lohman, T. G., Roche, A. F. & Martorell, R. Anthropometric Standardization Reference Manual (Human Kinetics Books, 1988)."},{"key":"73468_CR63","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ijo.2017.289","volume":"42","author":"SK Vasan","year":"2018","unstructured":"Vasan, S. K. et al. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int. J. Obes. 42, 850\u2013857 (2018).","journal-title":"Int. J. Obes."},{"key":"73468_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MOL.0b013e328353292e","volume":"23","author":"DS MacKay","year":"2012","unstructured":"MacKay, D. S. & Jones, P. J. H. Plasma noncholesterol sterols: current uses, potential and need for standardization. Curr. Opin. Lipidol. 23, 241\u2013247 (2012).","journal-title":"Curr. Opin. Lipidol."},{"key":"73468_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/0471142727.mb3004s114","volume":"114","author":"O Fiehn","year":"2016","unstructured":"Fiehn, O. Metabolomics by gas chromatography\u2013mass spectrometry: combined targeted and untargeted profiling. Curr. Protoc. Mol. Biol. 114, 31\u201330 (2016). 30.3434.32.","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"73468_CR66","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.numecd.2009.04.014","volume":"20","author":"MJ Nissinen","year":"2010","unstructured":"Nissinen, M. J., Miettinen, T. E., Gylling, H. & Miettinen, T. A. Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nutr., Metab. Cardiovasc. Dis. 20, 308\u2013316 (2010).","journal-title":"Nutr., Metab. Cardiovasc. Dis."},{"key":"73468_CR67","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/140139","volume":"2015","author":"A B\u00e9dard","year":"2015","unstructured":"B\u00e9dard, A. et al. Gender differences in the appetite response to a satiating diet. J. Obes. 2015, 140139 (2015).","journal-title":"J. Obes."},{"key":"73468_CR68","unstructured":"Hill, A. J. & Blundell, J. E. Macronutrients and satiety: the effects of a high-protein or high-carbohydrate meal on subjective motivation to eat and food preferences. Nutr. Behav. 3, 133\u2013144 (1986)."},{"key":"73468_CR69","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3945\/ajcn.112.047563","volume":"97","author":"A Belza","year":"2013","unstructured":"Belza, A. et al. Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety123.  Am. J. Clin. Nutr. 97, 980\u2013989 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"73468_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.appet.2013.01.023","volume":"65","author":"S Panahi","year":"2013","unstructured":"Panahi, S., El Khoury, D., Luhovyy, B. L., Goff, H. D. & Anderson, G. H. Caloric beverages consumed freely at meal-time add calories to an ad libitum meal. Appetite 65, 75\u201382 (2013).","journal-title":"Appetite"},{"key":"73468_CR71","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1006\/appe.1997.0096","volume":"29","author":"SM Green","year":"1997","unstructured":"Green, S. M., Delargy, H. J., Joanes, D. & Blundell, J. E. A satiety quotient: a formulation to assess the satiating effect of food. Appetite 29, 291\u2013304 (1997).","journal-title":"Appetite"},{"key":"73468_CR72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/dom.12749","volume":"18","author":"J-P Drouin-Chartier","year":"2016","unstructured":"Drouin-Chartier, J.-P. et al. Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance. Diab. Obes. Metab. 18, 1226\u20131235 (2016).","journal-title":"Diab. Obes. Metab."},{"key":"73468_CR73","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/ije\/dyh057","volume":"33","author":"MA Pereira","year":"2004","unstructured":"Pereira, M. A. et al. Within-person variation in serum lipids: implications for clinical trials. Int. J. Epidemiol. 33, 534\u2013541 (2004).","journal-title":"Int. J. Epidemiol."},{"key":"73468_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ajcn\/nqx013","volume":"107","author":"J-P Drouin-Chartier","year":"2018","unstructured":"Drouin-Chartier, J.-P. et al. Substitution of dietary \u03c9\u22126 polyunsaturated fatty acids for saturated fatty acids decreases LDL apolipoprotein B-100 production rate in men with dyslipidemia associated with insulin resistance: a randomized controlled trial. Am. J. Clin. Nutr. 107, 26\u201334 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"73468_CR75","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","volume":"365","author":"KF Schulz","year":"2005","unstructured":"Schulz, K. F. & Grimes, D. A. Multiplicity in randomised trials I: endpoints and treatments. Lancet 365, 1591\u20131595 (2005).","journal-title":"Lancet"},{"key":"73468_CR76","first-page":"1210","volume":"34","author":"I Ruel","year":"2018","unstructured":"Ruel, I. et al. Simplified Canadian definition for familial hypercholesterolemia. Can. J. Cardiol. 34, 1210\u20131214 (2018).","journal-title":"Can. J. Cardiol."},{"key":"73468_CR77","doi-asserted-by":"publisher","unstructured":"Morze, J. et al. ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf207 (2025).","DOI":"10.1093\/eurheartj\/ehaf207"},{"key":"73468_CR78","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones, D. M. et al. Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation 146, e18\u2013e43 (2022).","journal-title":"Circulation"},{"key":"73468_CR79","doi-asserted-by":"publisher","unstructured":"Lessard-Lord, J. et al. Jacob-Lessard-Lord\/FH_Diet_RCT_WFPB: FH_Diet_RCT_WFPB, https:\/\/doi.org\/10.5281\/zenodo.19607789 (2026).","DOI":"10.5281\/zenodo.19607789"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73468-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:02:44Z","timestamp":1784509364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73468-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73468"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73468-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JPDC discloses investigator-initiated research grants and consulting fees from the Dairy farmers of Canada and the Weston Family Foundation, unrelated to this work. Other authors have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6632"}}